Teva receives European Commission approvals for PONLIMSI® (denosumab) Biosimilar to Prolia® and DEGEVMA® (denosumab) Biosimilar to Xgeva®
Notified -
Globe Newswire25-11-2025, 20:10
EBC Financial Group Registers Trademark in Chile, Strengthening Its Latin American Footprint 11-11-2024, 10:49